# FUSCC

#### Necessary Disclaimers and Legal

The user is responsible for reviewing and complying with the license requirements of the data referenced in this documentation.

## Citations

The data in this project are downloaded from cBioPortal - study ID: [brca\_fuscc\_2020](https://www.cbioportal.org/study/summary?id=brca_fuscc_2020)

This dataset is described in the publication [Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial](https://pubmed.ncbi.nlm.nih.gov/32719455/).

## Available datasets

The tarball brca\_fuscc\_2020.tar.gz is untarred to a folder named [brca\_fuscc\_2020](https://platform.dnanexus.com/panx/projects/J3Bq2g8025V3v7QXxZ44pfq6/data/brca_fuscc_2020). This folder includes all clinical information related to the study.

File [brca\_fuscc\_2020\_clinical\_data.tsv](https://platform.dnanexus.com/panx/projects/J3Bq2g8025V3v7QXxZ44pfq6/data/?name=brca_fuscc_2020_clinical_data.tsv) contains clinical data of all the patients/samples in the study. Data for each patient/sample was downloaded directly from cBioPortal.

Files [41422\_2020\_375\_MOESM10\_ESM.xlsx](https://platform.dnanexus.com/panx/projects/J3Bq2g8025V3v7QXxZ44pfq6/data/?name=41422_2020_375_MOESM10_ESM.xlsx) and [41422\_2020\_375\_MOESM12\_ESM.xlsx](https://platform.dnanexus.com/panx/projects/J3Bq2g8025V3v7QXxZ44pfq6/data/?name=41422_2020_375_MOESM12_ESM.xlsx) are downloaded from the supplementary files of the publication "Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial" (PMID: 32719455)

* 41422\_2020\_375\_MOESM10\_ESM.xlsx (Supplementary file: Table S2): Characteristics of the patients in the FUTURE trial. Sample size: 69 patients and samples.
* 41422\_2020\_375\_MOESM12\_ESM.xlsx (Supplementary file: Table S4): Somatic mutation information of the prospective. Variants were annotated by Genome Nexus.